⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MCRB News
Seres Therapeutics, Inc.
Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
globenewswire.com
MCRB
Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025
globenewswire.com
MCRB
Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
globenewswire.com
MCRB
Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant
globenewswire.com
MCRB